CS1 A MARKOV MODELLED PHARMACOECONOMIC ANALYSIS OF BIMATOPROST 0.03% (LUMIGAN®) IN THE TREATMENT OF GLAUCOMA OR OCULAR HYPERTENSION AS AN ALTERNATIVE TO FILTRATION SURGERY IN ITALY

Authors:
  • MVM Vetrugno
    M Vetrugno
  • TCTl Christensen
    Tl Christensen
  • PPPb Poulsen
    Pb Poulsen
  • JWJ Walt
    J Walt
  • SHS Holmstrom
    S Holmstrom

Abstract
No abstract available